MU
36
-7
AZO
48
-10
TRV
52
10
WU
28
-2
WHR
70
-2
GPC
38
-5
CF
42
-3
INTC
47
4
LRCX
75
-3
AEP
61
5
STX
60
3
MMM
33
7
WAT
36
-2
CSX
48
-2
UPS
46
-4
CINF
54
4
ACN
38
-2
AN
43
2
CRM
64
5
PNW
46
-2
MU
36
-7
AZO
48
-10
TRV
52
10
WU
28
-2
WHR
70
-2
GPC
38
-5
CF
42
-3
INTC
47
4
LRCX
75
-3
AEP
61
5
STX
60
3
MMM
33
7
WAT
36
-2
CSX
48
-2
UPS
46
-4
CINF
54
4
ACN
38
-2
AN
43
2
CRM
64
5
PNW
46
-2
Financhill
Back

Alnylam Pharmaceuticals Quote, Financials, Valuation and Earnings

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.
Buy
51

ALNY
Alnylam Pharmaceuticals

Last Price:
243.56
Seasonality Move:
20.36%

7 Day Trial

ALL ACCESS PASS

$ 7

A massive $1 Trillion AI superproject is underway

Click here to discover these key companies behind this $1 trillion Superproject

Alnylam Pharmaceuticals Price Quote

$243.56
-3.44 (-1.39%)
(Updated: June 28, 2024 at 3:10 PM ET)

Alnylam Pharmaceuticals Key Stats

Buy
51
Alnylam Pharmaceuticals (ALNY) is a Buy
Day range:
$242.57 - $252.87
52-week range:
$141.98 - $252.87
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.65
P/B ratio:
0%
Volume:
2.6M
Avg. volume:
1.2M
1-year change:
30.83%
Market cap:
$31.2B
Revenue:
$1.8B
EPS:
$-2.68

How Much Does Alnylam Pharmaceuticals Make?

Is Alnylam Pharmaceuticals Growing As A Company?

Alnylam Pharmaceuticals Stock Price Performance

What Is Alnylam Pharmaceuticals 52-Week High & Low?

Alnylam Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Alnylam Pharmaceuticals?

Is Alnylam Pharmaceuticals Cash Flow Positive?

  • What Is ALNY Cash Flow From Operations?
    Cash flow from operations (TTM) is $189.1M
  • What Is Alnylam Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $154.7M
  • What Is Alnylam Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$327.8M

Alnylam Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ALNY return on invested capital is -43.4%
  • What Is Alnylam Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -9.08%
  • What Is ALNY Return On Equity?
    ROE is a measure of profitability and is 0%

Alnylam Pharmaceuticals Earnings Date & Stock Price

Alnylam Pharmaceuticals Competitors

Alnylam Pharmaceuticals Dividend Yield

Data Unavailable

Alnylam Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 74.5%
Revenue: 54.82% 15.82%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 10
Sell Recommendations: 0
Price Target: 247.17
Upside from Last Price: 0.07%

Major Shareholders

  • How many ALNY shares are owned by institutional investors?
    220.7M ALNY shares are owned by institutional investors
  • How many ALNY shares are owned by insiders?
    520.2K ALNY shares are owned by insiders